| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.042 | 0.4 |